Australia markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6412-0.0183 (-2.77%)
At close: 04:00PM EST
0.6500 +0.01 (+1.37%)
After hours: 07:56PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
0
0
0
0
0
Operating expenses
Research development
23,285
23,191
16,267
7,178
3,069
Selling general and administrative
10,461
8,758
6,930
6,556
6,610
Total operating expenses
33,746
31,949
23,197
13,734
9,679
Operating income or loss
-33,746
-31,949
-23,197
-13,734
-9,679
Interest expense
-
-
-
62
-
Total other income/expenses net
2,736
7,297
-7,731
1,955
-4,045
Income before tax
-30,934
-24,639
-30,774
-11,841
-13,724
Income tax expense
-
-
-
0
-1,650
Income from continuing operations
-30,934
-24,639
-30,774
-11,841
-12,074
Net income
-30,934
-24,639
-30,774
-13,335
-15,667
Net income available to common shareholders
-30,934
-24,639
-30,774
-13,335
-15,667
Basic EPS
-
-0.39
-0.90
-0.64
-1.75
Diluted EPS
-
-0.39
-0.90
-0.64
-1.75
Basic average shares
-
62,620
34,142
20,975
8,978
Diluted average shares
-
62,620
34,142
20,975
8,978
EBITDA
-
-29,995
-21,239
-11,771
-8,068